Literature DB >> 2657403

Continued withdrawal from the cell cycle and regulation of cellular genes in mouse erythroleukemia cells blocked in differentiation by the c-myc oncogene.

J A Coppola1, J M Parker, G D Schuler, M D Cole.   

Abstract

Constitutive expression of the c-myc oncogene blocks dimethyl sulfoxide (DMSO)-induced differentiation of mouse erythroleukemia (MEL) cells. During the first 12 h of treatment with DMSO, MEL cells undergo a temporary decrease in the level of c-myc mRNA, followed by a temporary withdrawal from the cell cycle. We found the same shutoff of DNA synthesis during the first 12 to 30 h after DMSO induction in normal MEL cells (which differentiate) and in c-myc-transfected MEL cells (which do not differentiate). We also examined whether deregulated c-myc expression grossly interfered with the regulation of gene expression during MEL cell differentiation. We used run-on transcription assays to monitor the rate of transcription of four oncogenes (c-myc, c-myb, c-fos, and c-K-ras); all except c-K-ras showed a rapid but temporary decrease in transcription after induction in both c-myc-transfected and control cells. Finally, we found the same regulation of cytoplasmic mRNA expression in both types of cells for four oncogenes and three housekeeping genes associated with growth. We conclude that in the MEL cell system, the effects of deregulated c-myc expression do not occur through a disruption of cell cycle control early in induction, nor do they occur through gross deregulation of gene expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657403      PMCID: PMC362590          DOI: 10.1128/mcb.9.4.1714-1720.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Differentiation in erythroleukemic cells and their somatic hybrids.

Authors:  S H Orkin; F I Harosi; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

Review 2.  Multiple regulatory steps control histone mRNA concentrations.

Authors:  W F Marzluff; N B Pandey
Journal:  Trends Biochem Sci       Date:  1988-02       Impact factor: 13.807

Review 3.  Erythroleukemic differentiation.

Authors:  P A Marks; R A Rifkind
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  Transient inhibition of initiation of S-phase associated with dimethyl sulfoxide induction of murine erythroleukemia cells to erythroid differentiation.

Authors:  M Terada; J Fried; U Nudel; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

5.  Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes.

Authors:  D W Cleveland; M A Lopata; R J MacDonald; N J Cowan; W J Rutter; M W Kirschner
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

Review 6.  Chemically induced murine erythroleukemic differentiation.

Authors:  R C Reuben; R A Rifkind; P A Marks
Journal:  Biochim Biophys Acta       Date:  1980-09-22

7.  Terminal differentiation in cultured Friend erythroleukemia cells.

Authors:  E A Friedman; C L Schildkraut
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

8.  FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA.

Authors:  T Curran; G Peters; C Van Beveren; N M Teich; I M Verma
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

9.  Lengthening of the G1 phase is not strictly correlated with differentiation in Friend erythroleukemia cells.

Authors:  E A Friedman; C L Schildkraut
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle.

Authors:  A Dugaiczyk; J A Haron; E M Stone; O E Dennison; K N Rothblum; R J Schwartz
Journal:  Biochemistry       Date:  1983-03-29       Impact factor: 3.162

View more
  5 in total

1.  Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells.

Authors:  G D Spotts; S R Hann
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense.

Authors:  J C Reed; M Cuddy; S Haldar; C Croce; P Nowell; D Makover; K Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  Treatment of HL-60 cells with dimethyl sulphoxide inhibits the formation of beta-N-acetylhexosaminidase S.

Authors:  C Emiliani; F Falzetti; A Orlacchio; J L Stirling
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

4.  The human cut homeodomain protein represses transcription from the c-myc promoter.

Authors:  D Dufort; A Nepveu
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

5.  Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc.

Authors:  B Hoffman-Liebermann; D A Liebermann
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.